Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.

Application of Platelet-Rich Plasma to Disorders of the Knee Joint.

Metcalf KB, Mandelbaum BR, McIlwraith CW.

Cartilage. 2013 Oct;4(4):295-312. doi: 10.1177/1947603513487553.

2.

An ex vivo model using human osteoarthritic cartilage demonstrates the release of bioactive insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Wardale J, Mullen L, Howard D, Ghose S, Rushton N.

Cell Biochem Funct. 2015 Jul;33(5):277-84. doi: 10.1002/cbf.3112. Epub 2015 Jun 9.

3.

Humoral and cell-mediated immune response, and growth factor synthesis after direct intraarticular injection of rAAV2-IGF-I and rAAV5-IGF-I in the equine middle carpal joint.

Ortved K, Wagner B, Calcedo R, Wilson J, Schaefer D, Nixon A.

Hum Gene Ther. 2015 Mar;26(3):161-71. doi: 10.1089/hum.2014.050.

4.

Bioactive IGF-1 release from collagen-GAG scaffold to enhance cartilage repair in vitro.

Mullen LM, Best SM, Ghose S, Wardale J, Rushton N, Cameron RE.

J Mater Sci Mater Med. 2015 Jan;26(1):5325. doi: 10.1007/s10856-014-5325-y. Epub 2015 Jan 11.

5.

Harnessing biomechanics to develop cartilage regeneration strategies.

Athanasiou KA, Responte DJ, Brown WE, Hu JC.

J Biomech Eng. 2015 Feb 1;137(2):020901. doi: 10.1115/1.4028825. Epub 2015 Jan 26. Review.

6.

Implantation of rAAV5-IGF-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model.

Ortved KF, Begum L, Mohammed HO, Nixon AJ.

Mol Ther. 2015 Feb;23(2):363-73. doi: 10.1038/mt.2014.198. Epub 2014 Oct 14.

7.

Down-regulation of programmed cell death 5 by insulin-like growth factor 1 in osteoarthritis chondrocytes.

Yi C, Ma C, Xie Z, Zhang G, Song W, Zhou X, Cao Y.

Int Orthop. 2013 May;37(5):937-43. doi: 10.1007/s00264-012-1744-x. Epub 2013 Jan 16.

8.

Differential regulation of immature articular cartilage compressive moduli and Poisson's ratios by in vitro stimulation with IGF-1 and TGF-beta1.

Williams GM, Dills KJ, Flores CR, Stender ME, Stewart KM, Nelson LM, Chen AC, Masuda K, Hazelwood SJ, Klisch SM, Sah RL.

J Biomech. 2010 Sep 17;43(13):2501-7. doi: 10.1016/j.jbiomech.2010.05.022. Epub 2010 Jun 8.

9.

Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold.

Mullen LM, Best SM, Brooks RA, Ghose S, Gwynne JH, Wardale J, Rushton N, Cameron RE.

Tissue Eng Part C Methods. 2010 Dec;16(6):1439-48. doi: 10.1089/ten.TEC.2009.0806. Epub 2010 May 22.

10.

Tissue engineering and cartilage.

Kessler MW, Grande DA.

Organogenesis. 2008 Jan;4(1):28-32.

11.

Systematic assessment of growth factor treatment on biochemical and biomechanical properties of engineered articular cartilage constructs.

Elder BD, Athanasiou KA.

Osteoarthritis Cartilage. 2009 Jan;17(1):114-23. doi: 10.1016/j.joca.2008.05.006. Epub 2008 Jun 20.

12.

Articular chondrocytes derived from distinct tissue zones differentially respond to in vitro oscillatory tensile loading.

Vanderploeg EJ, Wilson CG, Levenston ME.

Osteoarthritis Cartilage. 2008 Oct;16(10):1228-36. doi: 10.1016/j.joca.2008.02.016. Epub 2008 Apr 8.

13.

Dynamic matrix composition in engineered cartilage with stochastic supplementation of growth factors.

Saha AK, Mazumdar J, Kohles SS.

Australas Phys Eng Sci Med. 2005 Jun;28(2):97-104.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk